The Live Nagpur
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary

The Live Nagpur

  • Home
  • City
  • Politics
  • Business
  • Education
  • Entertainment
  • Sports
  • Health
  • Crime
  • Forest
  • Featured
  • Vidarbha
Featured

Nagpur based ZIM Laboratories Limited lists on the National Stock Exchange

by TLN Team November 28, 2022November 28, 2022
written by TLN Team November 28, 2022November 28, 2022
Nagpur based ZIM Laboratories Limited lists on the National Stock Exchange

Nagpur based ZIM Laboratories Ltd, a pharmaceutical company, focused on providing innovative drug delivery solutions that provide patient convenience and adherence of drug treatment, listed on the National Stock Exchange at Rs 336 per share.  

The shares of the company closed at Rs 332 per share. The total quantity traded at NSE stood at 34,653 shares, and the total Turnover stood at Rs 117.23 lakh.

The Market Capitalization of the Company at today’s closing price stood at Rs. 539.23 Cr on NSE and BSE respectively.

Dr. Anwar S Daud, Managing Director – Zim Laboratories Limited said “A big thank you for your support in helping us reach this important milestone, we are very happy with the NSE listing, and we believe that it will provide additional liquidity to our shareholders and it will also bring shareholders through NSE’s wide reach. We believe that it is important to continue our vision of making quality healthcare affordable through drug delivery solutions focusing on patient convenience and adherence. We have developed a portfolio of new innovative and   differentiated generic products which are at an advance stage of filing in EU and Pharmerging markets. We are also   developing unique differentiated nutraceutical products which are built around the existing pharmaceutical product portfolio for a holistic healthcare approach.  I wish to sincerely thank our shareholders for all their support and would like to mention our continued endeavour in creating value while developing products which provide unique benefits to our patients. 

The company uses its proprietary technology platforms for developing, manufacturing and supplying differentiated generic pharmaceutical and nutraceutical products in Finished Formulations (FF) as well as Pre-Formulation Intermediates (PFI) in various therapeutic categories which include Anti-Infective, Cardiovascular System, Gastrointestinal, Analgesic / NSAID, Urology, Vitamins and Dietary Supplements. 

It partners with Pharma and Distribution Companies which seek solutions for Development, Sourcing and Marketing for Pre Formulation Intermediates. In Finished Formulations – the company registers products in select markets, enters into marketing tie ups with local distribution/marketing companies and launches FF products as branded generics. 

Over the last 2 years (FY20 to FY22), Operating Income, EBITDA and PAT for the company has grown at a CAGR of 9.6%, 29% and 110% respectively. 

For the half year ending September 2022 (H1FY23), Operating Income grew 35.6% to Rs. 192 crore against Rs. 141 crore for the same period last year (H1FY22). EBITDA for H1FY23 grew to Rs 26.8 crore Vs Rs 17.6 crore in H1 FY22 and Net Profit was at Rs. 10.6 crore in H1 FY23 Vs Rs 3.45 crore in H1 FY22. Borrowings has also reduced from Rs 86.4 crore in H1 FY22 to Rs 63.3 crore in H1 FY23.  

0 comment
FacebookTwitterLinkedin
TLN Team

previous post
Demand for 2-way dash cameras on Jungle Safari vehicles
next post
Indian trains are expected to run at 130 km/h

You may also like

Sony India unveils the premium  Walkman®model NW-ZX707 with enhanced sound quality and...

January 30, 2023

NEW MAHINDRA ELECTRIC , XUV400UNVEILED AT PROVINCIAL AUTOMOBILE

January 30, 2023

Toyota Kirloskar Motor commences bookings for new Innova Crysta

January 30, 2023

Emotional Sania Mirza’s Grand Slam career comes to...

January 27, 2023

Sony introduces the FR7, the first PTZ camera...

January 25, 2023

Central Railway’s new general manager is Naresh Lalwani

January 25, 2023

Flipkart to host fourth edition of ‘Crafted By...

January 25, 2023

Know the eligibility criteria for a sports bike...

January 23, 2023

Jesse Lever confesses: “Johny Lever is our toughest critic!”

January 21, 2023

Sony redefines standard Zoom lens with launch of...

January 20, 2023

Leave a Comment Cancel Reply

Save my name, email, and website in this browser for the next time I comment.

Trending News

  • Watch spectators tease Shubham Gill ‘Hamari Bhabhi Kaisi Ho, Sara Bhabhi Jaisi Ho,’ During IND vs NZ 3rd ODI 2023 in Indore

    January 25, 2023
  • New rule for social media influencers, check below

    January 20, 2023
  • Ind vs NZ: Shubman Gill becomes youngest player to hit ODI double century

    January 18, 2023
  • 91 companies lays off more than 24,000 tech employees 

    January 16, 2023
  • Video of Indian shouting minutes before Nepal Plane crash

    January 16, 2023

Important Links

  • Politics
  • Crime
  • Business
  • Education
  • Entertainment
  • Sports

Available on Playstore & Coming Soon on Appstore

Search

November 2022
M T W T F S S
« Oct   Dec »
 123456
78910111213
14151617181920
21222324252627
282930  

Sign-Up Form

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Footer Logo
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary
  • Privacy Policy
  • Cookie Policy
  • Terms Of Use
  • Advertise with Us

© 2020 - The Live Nagpur . All Rights Reserved.